Table 6.
RAS–DS results
| RAS–DS domain | Mean score (SD) | ||
|---|---|---|---|
| Baseline | Follow-up | Change | |
| All Floresco clients at intake (n = 1129) | |||
| Doing things I value | 69.6% (16.2) | – | – |
| Looking forward | 64.2% (16.0) | – | – |
| Mastering my illness | 58.6% (16.7) | – | – |
| Connecting and belonging | 66.4% (17.5) | – | – |
| Overall | 64.7% (14.0) | – | – |
| All Floresco clients who completed the RAS–DS on two (or more) occasions (n = 108)a | |||
| Doing things I value | 70.4% (18.3) | 72.4% (17.3) | + 2.0% (15.3) |
| Looking forward | 62.9% (16.3) | 69.9% (17.9) | + 7.0% (16.8)*** |
| Mastering my illness | 56.1% (17.7) | 65.6% (18.6) | + 9.5% (18.9)*** |
| Connecting and belonging | 63.8% (18.4) | 68.8% (18.4) | + 5.0% (15.6)** |
| Overall | 63.3% (15.6) | 69.2% (16.1) | + 5.9% (14.3)*** |
| Follow-up study participants who completed both baseline and follow-up interviews (n = 37)b | |||
| Doing things I value | 72.0% (14.8) | 76.6% (14.9) | + 4.6% (20.5) |
| Looking forward | 65.6% (15.0) | 73.0% (14.3) | + 7.4% (21.6)* |
| Mastering my illness | 57.9% (17.1) | 71.2% (14.4) | + 13.3% (25.9)** |
| Connecting and belonging | 66.2% (17.5) | 74.2% (17.3) | + 8.0% (25.4) |
| Overall | 65.4% (13.1) | 73.8% (13.4) | + 8.3% (20.4)* |
Note: higher scores indicate higher levels of recovery
* p < 0.05; **p < 0.01; ***p < 0.001
a Average period between baseline and follow-up was 5.1 months. Dates when the RAS–DS was completed were available for 78 of the 108 clients (72.2%)
b Average period between baseline and follow-up was 6.3 months